Vosevi is a brand-name prescription medication used to treat chronic (long-lasting) hepatitis C in adults. It's approved for use in people whose disease hasn't been cured by taking certain other antiviral drugs.

Hepatitis C is a liver disease caused by infection with the hepatitis C virus (HCV). This virus has a few different strains, which are called genotypes. They all cause inflammation (swelling) and damage to the liver. They can also lead to liver cirrhosis (scarring) and liver failure.

Vosevi is approved to treat hepatitis C in:

  • people who don't have cirrhosis
  • people with compensated cirrhosis (where the liver is damaged but can still carry out its basic functions)
  • people with HCV genotype 1, 2, 3, 4, 5, or 6 who've tried antiviral drugs called nonstructural protein 5A (NS5A) inhibitors, which include elbasvir, ledipasvir, ombitasvir, and velpatasvir
  • people with HCV genotype 1a or 3 who've tried the antiviral drug called sofosbuvir, taken without an NS5A inhibitor

Vosevi is a type of medication called a direct-acting antiviral. It contains three active drug ingredients: sofosbuvir, velpatasvir, and voxilaprevir.

Vosevi comes as tablets that you take by mouth.

Effectiveness

Clinical studies have found Vosevi to be highly effective at curing hepatitis C. In these studies, people were considered cured of hepatitis C if no virus was detected in their blood 12 weeks after they completed treatment.

One study involved people who had previously tried treatment with antiviral drugs called NS5A inhibitors. The researchers compared Vosevi treatment with a placebo (a treatment with no active drug) in these people.

Hepatitis C was cured in 96% of people who took Vosevi for 12 weeks. It wasn't cured in any of the people who took a placebo.

For more information on effectiveness, see the "Vosevi for chronic hepatitis C" section.

FDA approval

The Food and Drug Administration (FDA) first approved Vosevi in 2017.

Vosevi is available only as a brand-name medication. It's not currently available in generic form.

Vosevi contains three active drug ingredients: sofosbuvir, velpatasvir, and voxilaprevir.

Vosevi can cause mild or serious side effects. The following lists contain some of the key side effects that may occur while taking Vosevi. These lists don't include all possible side effects.

For more information on the possible side effects of Vosevi, talk with your doctor or pharmacist. They can give you tips on how to deal with any side effects that may be bothersome.

Note: The Food and Drug Administration (FDA) tracks side effects of drugs they have approved. If you would like to report to the FDA a side effect you've had with Vosevi, you can do so through MedWatch.

More common side effects

The more common side effects of Vosevi can include:

  • nausea
  • fatigue (lack of energy)
  • feeling weak
  • trouble sleeping
  • headache (see "Side effect details" below)
  • diarrhea (see "Side effect details" below)

Most of these side effects may go away within a few days or a couple of weeks. If they're more severe or don't go away, talk with your doctor or pharmacist.

Serious side effects

Serious side effects from Vosevi aren't common, but they can occur. Call your doctor right away if you have serious side effects. Call 911 if your symptoms feel life threatening or if you think you're having a medical emergency.

Serious side effects are discussed in more detail below. They include:

  • serious allergic reactions
  • reactivation of the hepatitis B virus in people with both hepatitis B and hepatitis C*

*Vosevi has a boxed warning for this side effect. This is the most serious warning from the Food and Drug Administration (FDA). For more information, see "FDA warning: Reactivation of hepatitis B virus" at the beginning of this article.

Side effect details

You may wonder how often certain side effects occur with this drug. Here's some detail on some of the side effects this drug may cause.

Reactivation of the hepatitis B virus

If you've ever had a hepatitis B infection, taking Vosevi could reactivate the hepatitis B virus in your body.

Reactivation is when the hepatitis B virus becomes active again and starts to damage your liver. This can lead to liver failure and death. Reactivation can happen while you're taking Vosevi or after you've completed treatment. It's not known how often this occurs.

To avoid this problem, your doctor will do blood tests to check if you have the hepatitis B virus before you start Vosevi treatment. If you have the hepatitis B virus, you may need to take medication to treat it.

Allergic reaction

As with most drugs, some people have an allergic reaction after taking Vosevi. It's not known how often this occurs. It wasn't reported in clinical studies of Vosevi.

Symptoms of a mild allergic reaction can include:

  • skin rash
  • itchiness
  • flushing (warmth and redness in your skin)

A more severe allergic reaction is rare but possible. Symptoms of a severe allergic reaction can include:

  • swelling under your skin, typically in your eyelids, lips, hands, or feet
  • swelling of your tongue, mouth, or throat
  • trouble breathing

Call your doctor right away if you have a severe allergic reaction to Vosevi. Call 911 if your symptoms feel life threatening or if you think you're having a medical emergency.

Headache

Headaches may occur with Vosevi use. In clinical studies, this side effect was reported in 21% to 23% of people who took Vosevi. It was reported in 14% of people who took a placebo (a treatment with no active drug).

If you get headaches while taking Vosevi, ask your pharmacist to recommend a pain reliever.

Diarrhea

Vosevi may cause diarrhea. In clinical studies, this side effect was reported in 13% to 14% of people who took Vosevi. It was reported in 9% of people who took a placebo.

If you have diarrhea, make sure you drink plenty of fluids to avoid getting dehydrated.

Talk with your doctor or pharmacist if you have severe diarrhea (passing six or more watery stools in 24 hours), or diarrhea that lasts for more than a couple of days. They may recommend taking an antidiarrheal medication to manage it.

The following information describes dosages that are commonly used or recommended. However, be sure to take the dosage your doctor prescribes for you. Your doctor will determine the best dosage to fit your needs.

Drug forms and strengths

Vosevi comes as tablets that are available in one strength. Each tablet contains 400 mg of sofosbuvir, 100 mg of velpatasvir, and 100 mg of voxilaprevir.

Dosage for chronic hepatitis C

The recommended dosage is one Vosevi tablet taken once a day for 12 weeks. You should take Vosevi with food.

What if I miss a dose?

It's important that you don't miss or skip doses of Vosevi and that you take the full course of treatment. Missing doses or not completing the course will make Vosevi less effective against the hepatitis C virus. This could mean that your hepatitis C won't be cured.

To help make sure you don't miss a dose, try setting a reminder on your phone.

If you forget to take a dose at your usual time, take it as soon as you remember that day. But if you don't remember until the following day, just take your regular dose. Never take two doses to make up for a missed dose. This could raise your risk for getting side effects.

Will I need to use this drug long term?

No. Vosevi is meant to be used as one 12-week course of treatment.

Sticking to your Vosevi treatment plan

It's very important that you take Vosevi every day for 12 weeks. This will give you the best chance of curing your hepatitis C. It also will lower your risk of getting long-term complications from the disease, such as liver cirrhosis (scarring), liver failure, or liver cancer.

You should keep taking Vosevi for the entire time that your doctor recommends, even if you feel better before you finish the full course of treatment.

When you start treatment, pick a time of day that's most convenient for you to take Vosevi.

Getting in a routine for taking your medication will help you remember it. Setting a reminder on your phone can be helpful, too. Also, remember to take your medication with you if you're going away somewhere.

Talk with your doctor if you think you'll struggle to remember to take Vosevi every day.

You should avoid drinking alcohol while you're taking Vosevi to treat hepatitis C. Drinking alcohol could cause further damage to your liver. It can also increase your risk for getting Vosevi side effects such as headaches, diarrhea, nausea, and fatigue (lack of energy).

Talk with your doctor if you're concerned about avoiding alcohol during your Vosevi treatment.

Vosevi can interact with several other medications. It can also interact with certain supplements.

Different interactions can cause different effects. For instance, some interactions can interfere with how well a drug works. Other interactions can increase side effects or make them more severe.

Vosevi and other medications

Below is a list of medications that can interact with Vosevi. This list doesn't contain all drugs that may interact with Vosevi.

Before taking Vosevi, talk with your doctor and pharmacist. Tell them about all prescription, over-the-counter, and other drugs you take. Also tell them about any vitamins, herbs, and supplements you use. Sharing this information helps you avoid potential interactions.

If you have questions about drug interactions that may affect you, ask your doctor or pharmacist.

Vosevi and antacids

Antacids are drugs that relieve indigestion or heartburn. Taking Vosevi at the same time of day as an antacid can lower the amount of velpatasvir that your body absorbs. (Velpatasvir is one of the drugs in Vosevi.) This could make Vosevi less effective.

Examples of antacids that can make Vosevi less effective include:

  • sodium bicarbonate (an ingredient in some Alka-Seltzer products)
  • aluminum hydroxide/magnesium hydroxide/simethicone liquid (Maalox, Mylanta)
  • calcium carbonate/magnesium hydroxide (Rolaids)
  • calcium carbonate (Tums)

To avoid this interaction, don't take antacids in the 4 hours before or after you take your dose of Vosevi.

Vosevi and amiodarone

Amiodarone (Nexterone, Pacerone) is a drug used to treat serious types of irregular heartbeat.

Taking Vosevi with amiodarone can cause bradycardia (dangerously slow heartbeat). Some people taking these medications together needed a pacemaker to keep their heart beating regularly.

Vosevi is not recommended for people taking amiodarone unless there are no other options. If you have to take Vosevi and amiodarone together, your doctor will closely monitor your heart.

Vosevi and digoxin

Digoxin (Lanoxin) is a drug used to treat certain heart problems, including heart failure.

Taking Vosevi with digoxin can make the level of digoxin in your blood rise too high. This could cause serious side effects from the digoxin.

If you have to take Vosevi with digoxin, you'll need to have blood tests to monitor your digoxin level. If it gets too high, your doctor will likely lower your digoxin dose.

Vosevi and warfarin

Warfarin (Coumadin, Jantoven) is an anticoagulant (blood thinner) that treats and helps prevent blood clots. It works by reducing the production of proteins called clotting factors. Clotting factors help make your blood clot. They're made by your liver.

Your liver may start to work better as Vosevi treats your hepatitis C. This can change how many clotting factors your liver makes.

As a result, it might change the effect of warfarin in your blood. If you're taking Vosevi with warfarin, you may need extra blood tests to monitor how long it takes your blood to clot. Your doctor may increase or decrease your warfarin dose as needed.

Vosevi and dabigatran

Taking Vosevi with an anticoagulant (blood thinner) called dabigatran (Pradaxa) can increase the level of dabigatran in your blood. This can raise your risk for getting side effects from dabigatran, such as bruising or bleeding.

If you need to take Vosevi with dabigatran, tell your doctor if you notice you're bruising or bleeding more easily than usual.

For example, tell them if you get bruises you can't explain, cuts that take a long time to stop bleeding, nosebleeds that last a long time, or blood in your urine. Your doctor may need to lower your dabigatran dose.

Vosevi and certain cholesterol medications

Taking Vosevi with cholesterol-lowering medications called statins can increase the level of the statin in your blood. This can raise your risk for getting side effects from the statin, in particular muscle problems.

Examples of statin medications include:

  • atorvastatin (Lipitor)
  • fluvastatin (Lescol XL)
  • lovastatin (Altoprev)
  • pitavastatin (Livalo, Zypitamag)
  • pravastatin (Pravachol)
  • rosuvastatin (Ezallor, Crestor)
  • simvastatin (Flolipid, Zocor)

If you're taking a statin, talk with your doctor before you start treatment with Vosevi. Your doctor may need to lower the dose of your statin while you take Vosevi.

However, if you're taking pitavastatin or rosuvastatin, your doctor may switch you to a different statin. These two statins are not recommended for use with Vosevi.

Vosevi and certain seizure medications

Taking certain seizure medications with Vosevi can lower the amount of Vosevi in your body. This can make Vosevi less effective.

Examples of seizure medications that can make Vosevi less effective include:

  • carbamazepine (Carbatrol, Equetro, Tegretol, Epitol)
  • oxcarbazepine (Trileptal, Oxtellar XR)
  • phenobarbital
  • phenytoin (Dilantin, Phenytek)

These are not recommended for use with Vosevi.

If you're taking one of these medications, talk with your doctor before you start treatment with Vosevi. Your doctor may need to change your treatment.

Vosevi and certain antibiotics

Taking certain antibiotics with Vosevi can lower the amount of Vosevi in your body and make it less effective. To avoid this interaction, the following antibiotics should not be taken with Vosevi:

  • rifabutin (Mycobutin)
  • rifampin (Rifadin, Rimactane, Rifamate, Rifater)
  • rifapentine (Priftin)

Vosevi and certain HIV drugs

Vosevi can interact with certain types of HIV drugs. Talk with your doctor if you take an HIV drug and want to take Vosevi.

Atazanavir (Reyataz, Evotaz) or lopinavir (Kaletra)

HIV drugs containing atazanavir or lopinavir can increase the amount of voxilaprevir (one of the drugs in Vosevi) in your body. This could raise your risk for certain side effects. Taking Vosevi with atazanavir or lopinavir is not recommended.

Tipranavir (Aptivus) or ritonavir (Norvir, Kaletra)

HIV drugs containing tipranavir or ritonavir can lower the amount of sofosbuvir and velpatasvir (two of the drugs in Vosevi) in your body. This could make Vosevi less effective. Vosevi is not recommended for use with tipranavir or ritonavir.

Efavirenz (Sustiva, Atripla, Symfi)

HIV drugs containing efavirenz can lower the amount of velpatasvir and voxilaprevir (two of the drugs in Vosevi) in your body. This could make Vosevi less effective. Taking Vosevi with drugs containing efavirenz is not recommended.

Tenofovir disoproxil fumarate (Viread, Truvada, others)

Taking Vosevi with HIV drugs containing tenofovir disoproxil fumarate can increase the amount of tenofovir in your body. This could raise your risk for side effects. If you have to take these drugs together, your doctor may need to monitor you closely.

Vosevi and cyclosporine

Cyclosporine (Gengraf, Neoral, Sandimmune) is an immunosuppressant drug that weakens your immune system.

Taking Vosevi with cyclosporine could increase the amount of voxilaprevir (one of the drugs in Vosevi) in your body. This could raise your risk for side effects. Taking Vosevi with cyclosporine is not recommended.

Vosevi and herbs and supplements

Taking Vosevi with the herbal supplement St. John's wort (Hypericum perforatum) can lower the amount of Vosevi in your body. This could make it less effective. Avoid taking St. John's wort while you're taking Vosevi.

Check with your doctor or pharmacist before using any herbs or supplements while taking Vosevi.

The Food and Drug Administration (FDA) approves prescription drugs such as Vosevi to treat certain conditions.

Vosevi is FDA approved to treat chronic (long-lasting) hepatitis C in adults, when certain other treatments haven't worked.

Hepatitis C is a liver disease caused by infection with the hepatitis C virus (HCV). There are six main strains of this virus, which are called genotypes.

Vosevi is approved to treat chronic hepatitis C caused by:

  • genotypes 1, 2, 3, 4, 5, and 6 in people who've tried antiviral drugs called nonstructural protein 5A (NS5A) inhibitors such as elbasvir, ledipasvir, ombitasvir, or velpatasvir
  • genotype 1a or 3 in people who've tried the antiviral drug called sofosbuvir, taken without an NS5A inhibitor

Hepatitis C causes liver inflammation and damage to the liver. It can lead to liver cirrhosis (scarring) and liver failure.

Vosevi is approved for use in:

  • people who don't have cirrhosis
  • people with compensated cirrhosis (where the liver is damaged but can still carry out its basic functions)

Effectiveness

In two clinical studies, Vosevi cured chronic hepatitis C in the majority of people who took it for 12 weeks.

In these studies, the participants had blood tests to check for hepatitis C before, during, and after treatment with Vosevi. People were considered cured of hepatitis C if no virus was detected in their blood 12 weeks after they completed treatment.

The first study involved people who had already tried treatment with an NS5A inhibitor such as velpatasvir (one of the active drugs in Vosevi). Vosevi treatment was compared with a placebo (a treatment with no active drug).

Overall, hepatitis C was cured in 96% of people who took Vosevi for 12 weeks. Hepatitis C was not cured in any of the people who took a placebo. The cure rates varied slightly between people with different HCV genotypes.

Hepatitis C was cured in:

  • 97% of people with genotype 1 (the most common genotype)
  • 100% of people with genotype 2
  • 95% of people with genotype 3
  • 91% of people with genotype 4
  • 100% of people with genotype 5
  • 100% of people with genotype 6

The second study looked at people who had previously tried treatment with other direct-acting antivirals (the main type of hepatitis C drugs used) but who hadn't tried an NS5A inhibitor.

In this study, treatment with Vosevi (containing sofosbuvir, the NS5A inhibitor velpatasvir, and voxilaprevir) was compared to treatment with Epclusa (containing just sofosbuvir and velpatasvir).

After 12 weeks of treatment, hepatitis C was cured in 97% of people who took Vosevi. It was cured in 88% of people who took Epclusa.

However, Vosevi was only more effective than Epclusa in people with HCV genotypes 1a and 3. In people with genotypes 1b and 2, the drugs were similarly effective.

Other drugs are available that can treat hepatitis C. Some may be a better fit for you than others. If you're interested in finding an alternative to Vosevi, talk with your doctor. They can tell you about other medications that may work well for you.

Alternatives for chronic hepatitis C

Examples of other drugs that may be used to treat chronic (long-lasting) hepatitis C include:

Other direct-acting antivirals, such as:

  • elbasvir and grazoprevir (Zepatier)
  • glecaprevir and pibrentasvir (Mavyret)
  • ombitasvir, paritaprevir, ritonavir and dasabuvir (Viekira Pak)
  • sofosbuvir (Sovaldi)
  • sofosbuvir and ledipasvir (Harvoni)

sofosbuvir and velpatasvir (Epclusa)

Older, less commonly used medications, such as:

  • peginterferon alfa-2a (Pegasys)
  • peginterferon alfa-2b (Pegintron)
  • ribavirin (Rebetol, Ribasphere)

You may wonder how Vosevi compares to other medications that are prescribed for similar uses. Here we look at how Vosevi and Epclusa are alike and different.

Ingredients

Vosevi contains three active drugs: sofosbuvir, velpatasvir, and voxilaprevir. Epclusa contains two active drugs: sofosbuvir and velpatasvir.

Uses

Vosevi and Epclusa are both approved to treat chronic (long-lasting) hepatitis C in adults. Both can be used to treat all six main genotypes (strains) of the hepatitis C virus (HCV).

Vosevi is approved for use in people who've tried certain hepatitis C drugs in the past without success. Vosevi is specifically approved to treat:

  • people with HCV genotype 1, 2, 3, 4, 5, or 6 who've tried antiviral drugs called nonstructural protein 5A (NS5A) inhibitors
  • people with HCV genotype 1a or 3 who've tried an antiviral drug called sofosbuvir, taken without an NS5A inhibitor

Epclusa is approved for use in people who haven't tried any hepatitis C treatments in the past. It's also approved for those who've tried other treatments without success.

Vosevi and Epclusa are both approved for use in:

  • people without liver cirrhosis (scarring)
  • people with compensated cirrhosis (where the liver is damaged but still able to perform its basis functions)

Epclusa is also approved for use in people with decompensated cirrhosis (where the damage to the liver stops it from working properly). In this situation, Epclusa is used with another antiviral drug called ribavirin.

Drug forms and administration

Both Vosevi and Epclusa come as tablets that you take by mouth once daily for 12 weeks.

Side effects and risks

Vosevi and Epclusa both contain sofobuvir and velpatasvir. Therefore, these medications can cause very similar side effects. Below are examples of these side effects.

More common side effects

These lists contain examples of more common side effects that can occur with Vosevi or with both drugs (when taken individually).

  • Can occur with Vosevi:
    • diarrhea
  • Can occur with both Vosevi and Epclusa:
    • headache
    • fatigue (lack of energy)
    • nausea
    • feeling weak
    • trouble sleeping

Serious side effects

This list contains examples of serious side effects that can occur with both Vosevi and Epclusa (when taken individually).

  • Can occur with both Vosevi and Epclusa:

*Vosevi and Epclusa both have a boxed warning for this side effect. This is the most serious warning from the Food and Drug Administration (FDA). For more information, see "FDA warning: Reactivation of hepatitis B virus" at the beginning of this article.

Effectiveness

The use of Vosevi and Epclusa in treating chronic hepatitis C has been directly compared in a clinical study. This study only looked at people who had previously tried treatment with other direct-acting antivirals (the main type of hepatitis C drugs used) but who hadn't taken an NS5A inhibitor before.

Researchers found that in people with this treatment history, Vosevi was more effective than Epclusa at curing hepatitis C. However, the difference was only significant in people with certain genotypes of the hepatitis C virus (1a and 3):

  • In people with genotype 1a, hepatitis C was cured in 97% of those who took Vosevi and in 82% of those who took Epclusa.
  • In people with genotype 1b, hepatitis C was cured in 94% of those who took Vosevi and in 92% of those who took Epclusa.
  • In people with genotype 2, hepatitis C was cured in 100% of those who took Vosevi and in 97% of those who took Epclusa.
  • In people with genotype 3, hepatitis C was cured in 96% of those who took Vosevi and in 85% of those who took Epclusa.

This study didn't compare how effective these drugs are in people with genotype 4, 5, or 6.

Talk with your doctor about whether Vosevi or Epclusa is likely to be more effective for you.

Costs

Vosevi and Epclusa are both brand-name drugs. There's currently no generic form of Vosevi. Epclusa comes as a generic called sofosbuvir/velpatasvir. Brand-name medications usually cost more than generics.

According to estimates on GoodRx.com, Vosevi and Epclusa generally cost about the same.

The generic form of Epclusa is much less expensive than either brand-name drug. The actual price you'll pay for either drug will depend on your insurance plan, your location, and the pharmacy you use.

Like Epclusa (above), Mavyret has uses similar to those of Vosevi.

Here's a comparison of how Vosevi and Mavyret are alike and different.

Ingredients

Vosevi contains three active drugs: sofosbuvir, velpatasvir, and voxilaprevir. Mavyret contains two active drugs: glecaprevir and pibrentasvir.

Uses

Vosevi and Mavyret are both approved to treat chronic (long-lasting) hepatitis C in adults. Mavyret is also approved for use in children ages 12 years and older who weigh at least 99 pounds. Both can be used to treat the six main genotypes (strains) of the hepatitis C virus (HCV).

Vosevi is approved to treat:

  • people with HCV genotype 1, 2, 3, 4, 5, or 6 who've tried antiviral drugs called nonstructural protein 5A (NS5A) inhibitors
  • people with HCV genotype 1a or 3 who've tried an antiviral drug called sofosbuvir, taken without an NS5A inhibitor

Mavyret is approved to treat:

  • people with HCV genotype 1, 2, 3, 4, 5, or 6 who haven't had treatment before
  • people with HCV genotype 1, 2, 3, 4, 5, or 6 who've tried other hepatitis C treatments
  • people with HCV genotype 1 who've tried antiviral drugs called NS5A inhibitors or NS3/4A protease inhibitors, but not both

Vosevi and Mavyret are both approved for use in:

  • people without liver cirrhosis (scarring)
  • people with compensated cirrhosis (where the liver is damaged but still able to perform its basis functions)

Drug forms and administration

Vosevi and Mavyret both come as tablets that you take by mouth once daily.

Vosevi is taken for 12 weeks. Mavyret is taken for either 8, 12, or 16 weeks. Your treatment length will depend on what treatment you've already had and whether you have cirrhosis.

Side effects and risks

Vosevi and Mavyret have some similar side effects and others that differ. Below are examples of these side effects.

More common side effects

These lists contain examples of more common side effects that can occur with Vosevi, with Mavyret, or with both drugs (when taken individually).

  • Can occur with Vosevi:
    • feeling weak
    • trouble sleeping
  • Can occur with Mavyret:
    • itching
    • feeling weak (in people on dialysis)
  • Can occur with both Vosevi and Mavyret:
    • headache
    • fatigue (lack of energy)
    • nausea
    • diarrhea

Serious side effects

This list contains examples of serious side effects that can occur with Vosevi or Mavyret (when taken individually).

  • Can occur with both Vosevi and Mavyret:

*Vosevi and Mavyret both have a boxed warning for this side effect. This is the most serious warning from the Food and Drug Administration (FDA). For more information, see "FDA warning: Reactivation of hepatitis B virus" at the beginning of this article.

Effectiveness

Vosevi and Mavyret have slightly different FDA approved uses, but they're both used to treat chronic hepatitis C.

These drugs haven't been directly compared in clinical studies. However, studies have found both Vosevi and Mavyret to be highly effective for treating chronic hepatitis C caused by the six main genotypes. They're both recommended in current treatment guidelines for hepatitis C.

Your doctor may recommend either drug, depending on your medical history and treatment history.

Costs

Vosevi and Mavyret are both brand-name drugs. There are currently no generic forms of either drug. Brand-name medications usually cost more than generics.

According to estimates on GoodRx.com, Vosevi may cost significantly more than Mavyret. The actual price you'll pay for either drug will depend on your treatment length, your insurance plan, your location, and the pharmacy you use.

As with all medications, the cost of Vosevi can vary. To find current prices for Vosevi in your area, check out GoodRx.com.

The cost you find on GoodRx.com is what you may pay without insurance. The actual price you'll pay will depend on your insurance plan, your location, and the pharmacy you use.

It's important to note that Vosevi is only available at specialty pharmacies. These are pharmacies authorized to carry specialty medications (drugs that are complex, have high prices, are difficult to take, or have special dosage or storage requirements).

Your insurance plan may require you to get prior authorization before it approves coverage for Vosevi.

This means that your doctor and insurance company will need to communicate about your prescription before the insurance company will cover the drug. The insurance company will review the request and let you and your doctor know if your plan will cover Vosevi.

If you're not sure if you'll need to get prior authorization for Vosevi, contact your insurance plan.

Financial and insurance assistance

If you need financial support to pay for Vosevi, or if you need help understanding your insurance coverage, help is available.

Gilead Sciences Inc., the manufacturer of Vosevi, offers a program called Vosevi Support Path. For more information and to find out if you're eligible for support, call 855-7-MYPATH (855-769-7284) or visit the program website.

You should take Vosevi according to your doctor's or healthcare provider's instructions.

When to take

You should take Vosevi once a day with food. You can take it at any time of day, but try to always take it at the same time. Getting in a routine can help you remember to take your dose each day.

To help make sure you don't miss a dose, try setting a reminder on your phone. A medication timer may be useful, too.

Taking Vosevi with food

Take Vosevi with food (either a meal or a snack). This helps your body absorb the medication.

Can Vosevi be crushed, split, or chewed?

You shouldn't crush, split, or chew Vosevi tablets because they have a very bitter taste. Also, the effect of crushing, chewing, or breaking Vosevi hasn't been studied.

It could affect the way your body absorbs the medication. It's not known if this would change how safe or effective the drug is.

If you have trouble swallowing Vosevi tablets whole, talk with your doctor about your options for other treatments.

Vosevi is approved to treat chronic (long-lasting) hepatitis C in adults whose disease hasn't been cured by taking certain other antiviral drugs.

About hepatitis C

Hepatitis C is caused by being infected with the hepatitis C virus (HCV). You can get this virus through contact with the blood, or bodily fluids containing blood, of a person who has HCV.

Once inside your body, the virus multiplies by making copies of itself inside your liver cells. This causes inflammation (swelling) and damage to your liver.

Sometimes your immune system can fight off the hepatitis C virus itself. However, in about 75% to 85% of people this doesn't happen, and the infection becomes chronic.

Without treatment, chronic hepatitis C infection can lead to liver cirrhosis (scarring), liver failure, and liver cancer.

What Vosevi does

Vosevi is a type of drug called a direct-acting antiviral. It contains three active drugs: sofosbuvir, velpatasvir, and voxilaprevir. Each of these drugs works in a slightly different way to stop the hepatitis C virus from making copies of itself.

The hepatitis C virus uses certain proteins within the virus to make copies of itself. Each of the drugs in Vosevi stops a different protein from working. This means the virus can't multiply.

Viruses that can't make copies of themselves eventually die or are removed by your immune system. This clears up the infection and prevents further damage to your liver.

How long does it take to work?

Vosevi will start working right away, but you'll need to take the full 12-week course of treatment to cure the infection.

In a clinical study, hepatitis C was cured in 96% of people who took Vosevi for 12 weeks.

Your doctor will test your blood for the virus during treatment and 12 weeks after you finish treatment. If the virus is not detected in your blood 12 weeks after your treatment ends, you're considered cured of hepatitis C.

It's not known if Vosevi is safe to take during pregnancy. It hasn't been studied in pregnant women.

Studies in animals didn't show harm to the fetus when the mother was given any of the active drugs in Vosevi. However, studies in animals don't always predict what'll happen in humans.

If you're pregnant or considering becoming pregnant, talk with your doctor about your treatment options.

As mentioned above, it's unknown if Vosevi is safe for use during pregnancy. If you're sexually active and you or your partner can become pregnant, talk with your doctor about your birth control needs while you're using Vosevi.

It's not known if Vosevi is safe to take while breastfeeding. It's unknown if the active drugs in Vosevi pass into human breast milk.

In animal studies, the drugs were found in breast milk. However, studies in animals don't always predict what'll happen in humans.

If you're breastfeeding, talk with your doctor about the risks and benefits of taking Vosevi.

Here are answers to some frequently asked questions about Vosevi.

Why can't I get Vosevi at my local pharmacy?

Vosevi is only available at specialty pharmacies, which are authorized to carry specialty medications. These are drugs that are complex, have high prices, are difficult to take, or have special dosage or storage requirements.

Ask your doctor if you aren't sure where you can get Vosevi. They can recommend a specialty pharmacy in your area that carries it.

Will my doctor give me any tests before I take Vosevi?

Yes, your doctor will do blood tests to check for the hepatitis B virus before you start treatment.

If these tests show you have the hepatitis B virus, you may need to take medication to treat it. This is because taking Vosevi can make the hepatitis B virus become active in your body again, which can lead to liver failure and death.

Your doctor will also do blood tests to check your liver and kidney function. If the tests show your liver or kidneys are not working very well, you may not be able to take Vosevi.

Is it OK to use antacids during my Vosevi treatment?

Yes, you can take antacids during your treatment. However, don't take them in the 4 hours before or after you take your Vosevi dose.

Can Vosevi cure hepatitis C?

Yes, taking Vosevi for 12 weeks can cure hepatitis C in most people who've tried other treatments that haven't worked.

In one study, Vosevi cured hepatitis C in 96% of people who'd tried a type of drug called a nonstructural protein 5A (NS5A) inhibitor. In a second study, Vosevi cured hepatitis C in 97% of people who'd previously tried sofosbuvir without an NS5A inhibitor.

This drug comes with several precautions.

FDA warning: Reactivation of hepatitis B virus

This drug has a boxed warning. This is the most serious warning from the Food and Drug Administration (FDA). A boxed warning alerts doctors and patients about drug effects that may be dangerous.

If you've ever had hepatitis B, there's a risk that taking Vosevi could reactivate the hepatitis B virus in your body. Reactivation is when the virus becomes active again. It can lead to liver failure and death.

Your doctor will do blood tests to check for the hepatitis B virus before you start treatment with Vosevi. If these tests show you have the hepatitis B virus, you may need to take medication to treat it.

Other precautions

Before taking Vosevi, talk with your doctor about your health history. Vosevi may not be right for you if you have certain medical conditions or other factors affecting your health.

These include:

  • Treatment with rifampin. If you're taking the antibiotic rifampin (Rifadin, Rimactane, Rifamate, Rifater), you should not take Vosevi. Rifampin makes Vosevi much less effective.
  • Heart problems treated with amiodarone. If you're taking amiodarone (Nexterone, Pacerone) to treat a heart problem, taking Vosevi can lead to a dangerously slow heartbeat. Vosevi is not recommended for people taking amiodarone unless you have no other options. If you have to take Vosevi and amiodarone together, your doctor will closely monitor your heart.
  • Kidney problems. You may not be able to take Vosevi if you have severe kidney problems or end-stage kidney disease. Ask your doctor about other treatments that may be right for you.
  • Liver problems. You may not be able to take Vosevi if your hepatitis C has damaged your liver too much or if you have other problems with your liver. Also, Vosevi may cause worsening of liver problems in people with compensated cirrhosis (where the liver is damaged but still able to perform its basis functions). Ask your doctor what treatments may be right for you.
  • Pregnancy. It's not known if Vosevi is safe to take during pregnancy. For more information, see the "Vosevi and pregnancy" section above.
  • Breastfeeding. It's not known if the medications in Vosevi pass into breast milk. For more information, see the "Vosevi and breastfeeding" section above.

Note: For more information about the potential negative effects of Vosevi, see the "Vosevi side effects" section above.

Do not use more Vosevi than your doctor recommends.

If you think you've taken too much of this drug, call your doctor. You can also call the American Association of Poison Control Centers at 800-222-1222 or use their online tool.

If your symptoms are severe, call 911 or go to the nearest emergency room right away.

When you get Vosevi from the pharmacy, the pharmacist will add an expiration date to the label on the bottle. This date is typically 1 year from the date they dispensed the medication.

The expiration date helps guarantee that the medication is effective during this time.

The current stance of the Food and Drug Administration (FDA) is to avoid using expired medications. If you have unused medication that has gone past the expiration date, talk to your pharmacist about whether you might still be able to use it.

Storage

How long a medication remains good can depend on many factors, including how and where you store the medication.

Vosevi tablets should be stored at room temperature in the bottle they came in. Keep the bottle away from light and tightly closed. Avoid storing this medication in areas where it could get damp or wet, such as bathrooms.

Disposal

If you no longer need to take Vosevi and have leftover medication, it's important to dispose of it safely. This helps prevent others, including children and pets, from taking the drug by accident. It also helps keep the drug from harming the environment.

The FDA website provides several useful tips on medication disposal. You can also ask your pharmacist for information on how to dispose of your medication.

The following information is provided for clinicians and other healthcare professionals.

Indications

Vosevi is indicated to treat chronic hepatitis C in adults without cirrhosis or with compensated cirrhosis.

Vosevi is approved to treat the hepatitis C virus (HCV) infection caused by:

  • genotypes 1, 2, 3, 4, 5, or 6 in people previously treated with nonstructural protein 5A (NS5A) inhibitors (including elbasvir, ledipasvir, ombitasvir, and velpatasvir)
  • genotype 1a or 3 in people previously treated with sofosbuvir without an NS5A inhibitor

Recommended dosage is one tablet once a day for a treatment duration of 12 weeks. It should be taken with food.

Mechanism of action

Vosevi is a direct-acting antiviral drug containing sofosbuvir, velpatasvir and voxilaprevir.

Sofosbuvir is a prodrug that's metabolized into a nucleotide analogue. This metabolite is an inhibitor of HCV NS5B RNA-dependent RNA polymerase. It's incorporated into HCV RNA and acts as a chain terminator, thereby stopping HCV replication.

Velpatasvir is an HCV NS5A protein inhibitor. This protein is involved in viral RNA replication, and is also required by the virus to assemble new viral copies. Velpatasvir stops HCV replication.

Voxilaprevir is an HCV NS3/4A protease inhibitor. This enzyme is involved in breaking down viral polyproteins into individual proteins such as NS5A and NS5B. It also stops HCV replication.

Pharmacokinetics and metabolism

Sofosbuvir reaches maximum concentrations 2 hours after taking Vosevi tablets. Mean exposure is improved by 64% to 144% when Vosevi is taken with food. Sofosbuvir is metabolized to the active metabolite uridine analog triphosphate and then to an inactive metabolite in the liver.

Most of the dose is excreted in the urine. The half-life of sofosbuvir is 30 minutes, and the half-life of the metabolite is 29 hours.

Velpatasvir reaches peak concentrations 4 hours after taking Vosevi. Mean exposure is increased by 40% to 166% when the drug is taken with food. Velpatasvir is more than 99% bound to plasma proteins.

It's metabolized in the liver by CYP3A4, CYP2C8, and CYP2B6. Of the dose administered, 94% of the dose is excreted in the feces, with 77% as the parent drug. The half-life of velpatasvir is 17 hours.

Voxilaprevir reaches its peak concentration 4 hours after taking Vosevi. Mean exposure is 112% to 435% higher when the drug is taken with food.

Voxilaprevir is more than 99% bound to plasma proteins. It's metabolized in the liver by CYP3A4. Of the dose administered, 94% of the dose is excreted in the feces, with 40% as the parent drug. Voxilaprevir has a half-life of 33 hours.

Contraindications

Vosevi is contraindicated in people taking rifampin.

Storage

Vosevi tablets should be stored in their original bottle at room temperature, below 86°F (30°C).

Disclaimer: Medical News Today has made every effort to make certain that all information is factually correct, comprehensive, and up to date. However, this article shouldn't be used as a substitute for the knowledge and expertise of a licensed healthcare professional. You should always consult your doctor or other healthcare professional before taking any medication. The drug information contained herein is subject to change and is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. The absence of warnings or other information for a given drug does not indicate that the drug or drug combination is safe, effective, or appropriate for all patients or all specific uses.